F4X-30239-29679
2 vaccinations
6 coded responses
24 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 287 / NC
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Pfizer-BioNTech
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-08
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Fuzzy headMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-10
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Injection site mass, Tenderness — Feeling: Good · Site: PainFree text: Injection site has hard lump under skin and very tender to the touch. More each day instead of less.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-13
- 2021-04-15
- 2021-04-22
- 2021-04-29
-
2021-05-06
Survey response — day 28, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Be unable to workFree text: Felt like I was getting a cold yesterday. Had all the symptoms. They went away by today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-13
- 2021-05-20
-
2021-07-08
Survey response — 3 months, dose 2MedDRA: Diarrhoea, Fatigue — Feeling: FairFree text: Digestive issues (diarrhea) and very tired.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-07
Survey response — 6 months, dose 2MedDRA: Menstruation irregular, Premenstrual dysphoric disorder, Premenstrual syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: My periods are worse and so is pms. To the point of PMDD.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-10
Survey response — 12 months, dose 2MedDRA: Hormone level abnormal, Menstruation irregular, Office visit, Premenstrual dysphoric disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I have had a lot of hormonal struggles since the vaccine. My period is earlier than it's ever been and I've developed PMDD. The week before my period I am almost nonfunctional most of the time. · Healthcare visit (other): Regular PCP and OBGYN visitsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-10
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-13
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Fuzzy head
Systemic reaction (other): Injection site has hard lump under skin and very tender to the touch. More each day instead of less.
Release 8 — day 28, dose 2
Symptoms: Felt like I was getting a cold yesterday. Had all the symptoms. They went away by today.
Release 9 — 3 months, dose 2
Symptoms: Digestive issues (diarrhea) and very tired.
Release 10 — 6 months, dose 2
Symptoms: My periods are worse and so is pms. To the point of PMDD.
Release 11 — 12 months, dose 2
Symptoms: I have had a lot of hormonal struggles since the vaccine. My period is earlier than it's ever been and I've developed PMDD. The week before my period I am almost nonfunctional most of the time.
Healthcare visit (other): Regular PCP and OBGYN visits
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hormone level abnormal | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Premenstrual dysphoric disorder | · | · | ✓ |
| SD | Premenstrual syndrome | · | · | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release